HPR40 Cost-Effectiveness and Budget Impact of Baloxavir Marboxil in the Netherlands Based on Post-COVID Influenza Season Scenarios
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1172
https://www.valueinhealthjournal.com/article/S1098-3015(22)03377-0/fulltext
Title :
HPR40 Cost-Effectiveness and Budget Impact of Baloxavir Marboxil in the Netherlands Based on Post-COVID Influenza Season Scenarios
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03377-0&doi=10.1016/j.jval.2022.09.1172
First page :
Section Title :
Open access? :
No
Section Order :
10718